User contributions
Jump to navigation
Jump to search
- 06:59, 4 December 2016 diff hist -92 m Cutaneous basal cell carcinoma Text replacement - "<span style="background:#00cd00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
- 06:58, 4 December 2016 diff hist -368 m Multiple myeloma - historical Text replacement - "<span style="background:#00cd00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:58, 4 December 2016 diff hist -184 m HIV-associated lymphoma Text replacement - "<span style="background:#00cd00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:58, 4 December 2016 diff hist -1,564 m Diffuse large B-cell lymphoma - historical Text replacement - "<span style="background:#00cd00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:56, 4 December 2016 diff hist -184 m Hypereosinophilic syndrome Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Case report</span>" to "style="background-color:#FF0000"|Case report"
- 06:56, 4 December 2016 diff hist -92 m Acquired hemophilia A Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Case report</span>" to "style="background-color:#FF0000"|Case report"
- 06:55, 4 December 2016 diff hist -92 m Burkitt lymphoma Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Pilot, <20 patients reported</span>" to "style="background-color:#FF0000"|Pilot, <20 patients reported"
- 06:55, 4 December 2016 diff hist -184 m Soft tissue sarcoma Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Pilot, <20 patients reported</span>" to "style="background-color:#FF0000"|Pilot, <20 patients reported"
- 06:54, 4 December 2016 diff hist -92 m Immune thrombocytopenia Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Pilot, <20 patients reported</span>" to "style="background-color:#FF0000"|Pilot, <20 patients reported"
- 06:54, 4 December 2016 diff hist -92 m Systemic mastocytosis Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Pilot, <20 patients reported</span>" to "style="background-color:#FF0000"|Pilot, <20 patients reported"
- 06:54, 4 December 2016 diff hist -460 m Cutaneous basal cell carcinoma Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Pilot, <20 patients reported</span>" to "style="background-color:#FF0000"|Pilot, <20 patients reported"
- 06:03, 4 December 2016 diff hist -184 m HIV-associated lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:03, 4 December 2016 diff hist -92 m Prostate cancer Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:02, 4 December 2016 diff hist -460 m Diffuse large B-cell lymphoma - historical Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:02, 4 December 2016 diff hist -92 m Chronic myeloid leukemia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:01, 4 December 2016 diff hist -92 m Waldenström macroglobulinemia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:01, 4 December 2016 diff hist -184 m Burkitt lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:01, 4 December 2016 diff hist -644 m Acute promyelocytic leukemia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:00, 4 December 2016 diff hist -184 m CNS lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:00, 4 December 2016 diff hist -184 m Transplant conditioning regimens Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:00, 4 December 2016 diff hist -552 m Classical Hodgkin lymphoma - historical Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 05:59, 4 December 2016 diff hist -184 m Autoimmune cytopenia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -184 m Hypereosinophilic syndrome Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -92 m Immune thrombocytopenia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -276 m CNS lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -276 m HIV-associated lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -644 m Transplant conditioning regimens Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -276 m Cold agglutinin disease Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -276 m Anaplastic glioma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -276 m Aplastic anemia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -552 m Diffuse large B-cell lymphoma - historical Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -184 m Cutaneous T-cell lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -460 m Chronic myeloid leukemia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -92 m Classical Hodgkin lymphoma - historical Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:58, 4 December 2016 diff hist -276 m Burkitt lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:57, 4 December 2016 diff hist -368 m Plasma cell leukemia Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 05:57, 4 December 2016 diff hist -92 m Adult T-cell leukemia-lymphoma Text replacement - "<span style="background:#eeee00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 03:28, 2 December 2016 diff hist +93 m Transplant conditioning regimens Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:28, 2 December 2016 diff hist +4 m Hemophagocytic lymphohistiocytosis Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:27, 2 December 2016 diff hist +1 m Palbociclib (Ibrance) Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:27, 2 December 2016 diff hist +9 m Acquired thrombotic thrombocytopenic purpura Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:26, 2 December 2016 diff hist +16 m Systemic mastocytosis Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:26, 2 December 2016 diff hist +1 m Abexinostat (PCI-24781) Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:25, 2 December 2016 diff hist +2 m Chronic myelomonocytic leukemia Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:24, 2 December 2016 diff hist +6 m Editing test page Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:24, 2 December 2016 diff hist +3 m Masitinib (AB-1010) Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:23, 2 December 2016 diff hist +2 m Mepolizumab (Nucala) Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:22, 2 December 2016 diff hist +4 m Cixutumumab (IMC-A12) Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:22, 2 December 2016 diff hist +1 m Neuroblastoma Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
- 03:21, 2 December 2016 diff hist +134 m Esophageal cancer Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"